COPENHAGEN, Aug. 26, 2025 /PRNewswire/ -- Curasight A/S ("Curasight" or "the Company") (CPH: CURAS), a clinical stage radiopharmaceuticals company, today announced the European Medicines Agency (EMA) ...
COPENHAGEN, Aug. 26, 2025 /PRNewswire/ -- Curasight A/S ("Curasight" or "the Company") (CPH: CURAS), a clinical stage radiopharmaceuticals company, today announced the European Medicines Agency (EMA) ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈